Back to discover
Disease

Paramyxoviridae Infections

Clinical development underwayEmerging research
MeSHParamyxoviridae Infections
1
Publications
2
Clinical trials
2019
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
2
All trials
0
Active
0
Late-stage
2
Completed
Recently completed

Phase I Study to Determine the Safety, Infectivity, and Tolerability of 2 Doses of Live Attenuated Recombinant Cold-Passaged (cp) 45 Human Parainfluenza Type 3 Virus Vaccine, rHPIV3cp45, Lot PIV3#102A, Delivered as Nose Drops to HPIV3-Seronegative Infants and Children 6 to 36 Months of Age, at a 6 Month Interval

Phase 1 · Completed · National Institute of Allergy and Infectious Diseases (NIAID)

A Phase 1 Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Chimeric Bovine/Human Parainfluenza Type 3 Virus Vaccine, rB/HPIV3, Lot PIV3 #101A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV3-Seropositive Children 15 to 59 Months of Age, and HPIV3-Seronegative Infants and Children 6 to 36 Months of Age

Phase 1 · Completed · National Institute of Allergy and Infectious Diseases (NIAID)

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Global Health1
Leading journals1
  • The Lancet. Global health1
Leading researchers8
  • Bassat Q1
  • Brooks WA1
  • Campbell H1
  • Cohen C1
  • Li Y1
  • Moore DP1
  • Nair H1
  • Nunes M1
Affiliations (unnormalised)6
  • Centre for Global Health Research1
  • Centre for Respiratory Disease and Meningitis1
  • Chris Hani Baragwanath Academic Hospital and Faculty of Health Sciences1
  • Germany; School of Medicine1
  • Hospital Clínic-Universitat de Barcelona1
  • International Vaccine Access Center1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.

Identifiers
MeSHParamyxoviridae Infections
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.